Clotting Disorders

A collection of features and news articles published in ASH Clinical News related to clotting disorders.

On location

Direct Oral Anticoagulants Versus LMWH in Preventing Recurrent VTE in Cancer

At the 2021 ASCO Annual Meeting, two posters reported results from the CANVAS trial, which described the risk-benefit profiles of direct oral anticoagulants (DOACs)...
On location

Edoxaban Likely Prevents VTE Recurrence in Patients With Lung Cancer, Despite High Rates of...

Many clinicians who manage patients with advanced lung cancer have frequently observed high rates of venous thromboembolism (VTE), but neither the incidence of VTE...

Dabigatran Etexilate Approved for Children with VTE

The U.S. Food and Drug Administration (FDA) has approved dabigatran etexilate oral pellets for the treatment of children ages three months to 12 years...

Extended Thromboprophylaxis Does Not Reduce VTE Incidence in Hospitalized Patients With Cancer

The use of extended thromboprophylaxis with enoxaparin, betrixaban, or rivaroxaban does not reduce the risk of venous thromboembolic (VTE) events in hospitalized patients with...

Vincent Wagner and Ellen Marcus: Use of the Khorana Score to Predict VTE

Vincent Wagner, MD, and Ellen Marcus, BA, discuss the Khorana score's role in assessing risk of venous thromboembolism (VTE) in patients with gynecological cancers.